Guido Brink is Vice President of Regulatory Affairs and EU Market Access and joined the Company in 2003. He has over 20 years of experience in the oncology field and an extensive background in quality assurance systems in the field of molecular diagnostics. Prior to joining the Company, Guido spent 12 years at the Netherlands Cancer Institute (NKI) where he supervised the development of biotechnology quality control systems as member of Laura van ‘t Veer’s research team, co-founder of Agendia.